Literature DB >> 10447743

Induction of abortive and productive proliferation in resting human T lymphocytes via CD3 and CD28.

Y Müller1, H Wolf, E Wierenga, G Jung.   

Abstract

How the T-cell receptor (TCR)/CD3 complex mediates positive as well as negative signals for T-cell regulation is not fully understood. We have previously described the induction of anergy in resting human T lymphocytes after mitogenic, high-dose CD3 triggering with monoclonal antibodies. Here we report the concomitantly occurring cell death to be largely caused by apoptosis, which mainly affects the CD4+ T-helper population. Because cell death becomes detectable after initial cell proliferation, it appears that a high-dose CD3 stimulus constitutes a negative signal for resting T cells leading to an 'abortive proliferation' that is followed by anergy and/or apoptosis of the cells. In contrast, if initial proliferation is induced by a low dose of anti-CD3 in the presence of an accessory signal via the CD28 receptor, anergy and cell death are markedly reduced and 'productive proliferation' may occur. Productive proliferation is characterized by an increased secretion of various cytokines measured (interleukin (IL)-2, IL-4, IL-6, IL-10, tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma)). A low-dose submitogenic CD3 stimulus induced neither anergy nor cell death, supporting the view that negative CD3 signalling requires proliferation of resting cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447743      PMCID: PMC2326844          DOI: 10.1046/j.1365-2567.1999.00744.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.

Authors:  C P Larsen; E T Elwood; D Z Alexander; S C Ritchie; R Hendrix; C Tucker-Burden; H R Cho; A Aruffo; D Hollenbaugh; P S Linsley; K J Winn; T C Pearson
Journal:  Nature       Date:  1996-05-30       Impact factor: 49.962

2.  CD28 costimulation prevents cell death during primary T cell activation.

Authors:  P J Noel; L H Boise; J M Green; C B Thompson
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

3.  IL-6 rescues resting mouse T cells from apoptosis.

Authors:  T K Teague; P Marrack; J W Kappler; A T Vella
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

4.  Differential regulation of bcl-2 and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4+ helper T cells. A model for the long-term survival of memory cells.

Authors:  D L Mueller; S Seiffert; W Fang; T W Behrens
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

5.  Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.

Authors:  W W Hancock; M H Sayegh; X G Zheng; R Peach; P S Linsley; L A Turka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines.

Authors:  S Cayeux; C Beck; A Aicher; B Dörken; T Blankenstein
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

7.  CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response.

Authors:  L G Radvanyi; Y Shi; H Vaziri; A Sharma; R Dhala; G B Mills; R G Miller
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

8.  Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.

Authors:  G Yang; K E Hellström; I Hellström; L Chen
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

9.  Th2 cell clonal anergy as a consequence of partial activation.

Authors:  J Sloan-Lancaster; B D Evavold; P M Allen
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  A reassessment of the role of B7-1 expression in tumor rejection.

Authors:  T C Wu; A Y Huang; E M Jaffee; H I Levitsky; D M Pardoll
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  1 in total

1.  Differential requirements for induction of total immunoglobulin and physiological rheumatoid factor production by human peripheral blood B cells.

Authors:  W J Van Esch; C C Reparon-Schuijt; E W Levarht; C Van Kooten; F C Breedveld; C L Verweij
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.